Usage and Purchase Guide for Assimini Lao Edition

Asiminib, a highly potent tyrosine kinase inhibitor, is designed to treat adult patients with Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML). This drug can effectively inhibit the proliferation of abnormal white blood cells by precisely targeting the BCR-ABL1 tyrosine kinase, thereby helping patients control their disease. It is worth noting that Lucius Pharmaceuticals in Laos has successfully launched a generic version of Aceminid. Its price is more affordable than the original version. Products of the same specification only cost about 4,000 yuan, which undoubtedly brings an affordable treatment option to many patients.

When using Aceminid, patients must strictly follow their doctor’s instructions. For patients with newly diagnosed or previously treated Ph+ CML-CP, the recommended dose is 80 mg orally at approximately the same time daily, or 40 mg in two divided doses approximately 12 hours apart. Importantly, Aceminid should be taken on an empty stomach and avoid eating for 2 hours before and 1 hour before and after taking the drug. For Ph+ CML-CP patients with T315I mutation, the recommended dose is adjusted to 200 mg twice daily, which also needs to be taken on an empty stomach.

In the case of missed doses, patients on the once-daily dosing regimen should skip the dose and continue to take the next dose as planned if they miss the dose for more than 12 hours; patients on the twice-daily dosing regimen should also skip the dose and continue with the original plan if they miss the dose for more than 6 hours. When taking, tablets should be swallowed whole and not broken, crushed or chewed. Do not change the dosage, medication schedule, or stop treatment unless explicitly instructed by your attending physician.

When purchasing Asiminib, patients should remain vigilant and choose formal channels. It is recommended to consult overseas medical institutions with relevant qualifications and good reputation to ensure reliable sources of medicines. After receiving the medicine, you should carefully check whether the outer packaging is intact, check the product information, and verify the authenticity of the medicine by scanning the anti-counterfeiting mark to ensure the safety of the medicine.

In short, the Lao version of Acemini provides a cost-effective treatment option forPh+ CML patients. During use, patients should strictly follow the doctor's instructions, pay attention to the details of taking the medicine, and purchase medicines through formal channels to ensure the treatment effect and their own safety.

References:

https://www.drugs.com/history/scemblix.html

https://www.drugs.com/pro/scemblix.html#s-34090-1